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Diabetes is one of the most common metabolic diseases in the world. Vitamin E reduces protein glycation and 
improves insulin sensitivity, while cumin is effective in remission of diabetes. Therefore this study was designed 
to evaluate the effects of vitamin E and cumin essential oil, on the blood level of leptin,glycosylated hemoglobin 
(HbA1C) and also on lipid profile in diabetic patients.In this double blind clinical trial, 95 diabetic patients were 
selected and randomly dividedinto three groups.The first group received cumin essential oil in capsule form. The 
second group received Vitamin E, and the third group was used ascontrol receiving oral gelatin capsules as 
placebo for three months period.Blood glucose, lipid profile, apolipoprotein A1 (ApoA1), apolipoprotein B 
(ApoB), leptin, HbA1c, oxidized LDL (oxLDL), and paraoxonase1 activity were measured. The results showed 
reduction in oxLDL and significant increase in paraoxonase 1 in Vitamin E group by the end of the third month 
period (P<0.05). Cumin group showed decrease in blood glucose, HbA1C, triglyceride, leptin and ox-LDL. 
ApoA1 and paraoxonase1 were also increased by cumin treatment (P<0.05).Diabetic complications may have 
been reduced by intake of Vitamin E and cumin essential oil. Cumin in comparison with vitamin E has broader 
impact and it is more beneficial in terms of ability to reduce the diabetic index. 
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iabetes is one of the most common metabolic 
diseases in the world,and several factors are 
involved in its pathogenesis (1). Glycosylated 
hemoglobin (HbA1c) is formed by an irreversible, 
nonenzymatic binding of glucose to hemog-
lobin.HbA1c is a marker of metabolic regulation in 
diabetic patients. Incomplete metabolic regulation 
in diabetes is the leading cause of various 
complications,giving rise to oxidizing compounds 
(2). Leptin is a polypeptide hormone secreted by 
adipose tissue and involved in the control of body 
weight (3). Insulin is an important regulator for 
leptin and could have an impact onthe expression  
of the gene encoding leptin and also on the 
D
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corresponding receptor (4). Vitamin E reduces the 
oxidation of lipoproteins, oxidative damage of the 
endothelium, proteins glycation, and consequently 
improves insulin sensitivity (5). Some studies have 
shown that low levels of vitamin E are directly 
associated with diabetes, causing diabetes compli-
cations (6). There are contradictory data on the 
effect of vitamin E on insulin and blood  
sugar (7). 
Cumin is an herbaceous aromatic plant, 
yearlong; in the Apiaceae family with the scientific 
name of "cuminum cyminum". Cumin is harvested 
in Iran and it is used in traditional medicine, drinks 
flavor and desserts, and also as a fragrant compo-
nent in creams, lotions and perfumes.Cumin is used 
in the treatment of various diseases and is effective 
in remission of diabetes. The fruit of cumin 
contains 2-5% essential oil which is mainly made of 
paracetamol, alpha and beta pinene, propanal, 
cumin alcohol, cuminaldehyde, alpha terpineol and 
myrcene (8). 
In a study comparing the anti-diabetic efficacy 
of cumin and glibenclamide, cumin effects in 
preventing the free radical formation, decreasing 
glucose and protein glycation end products was 
very much improved in comparison with gliben-
clamide (9). In another study, the impact of cumin 
on blood glucose and oxidized LDL (oxLDL) 
decrease, and increase in arylesterase activity of 
paraoxonase 1 was reported (10). 
Increased activity of paraoxonase 1 induces an 
increase in the concentration of HDL in serum, 
confirming that increased paraoxonase 1 activity 
leads to less cardiovascular disease in humans (11). 
The present study was designed to evaluate the 
effect of vitamin E and cumin essential oil, on 
blood leptin, HbA1c and lipid profile of diabetic 
patients. 
 
Materials and methods 
Patient selection and sampling 
This study was approved by the Medical Research 
Ethics Committee of Shahrekord University of 
Medical Sciences and was recorded in the registry 
of clinical trials Iran with IRCT2014100619420N1 
code. Consent forms and the questio-nnaires were 
signed and filled in by all patients. 
In this double blind clinical trial study, 105 
diabetic patients were recruited. Patients with at 
least 3 years disease history were referred by an 
internal medicine physicians after interview and 
patient’s consent. All patients were under treatment 
with metformin as antidiabetic drug. 
Inclusion criteria were as follows: patients 
with type 2 diabetes without obvious complication 
who were aged 30-75 years (7), while smokers, 
subjects with the underlying disease such as 
cardiovascular disease and other metabolic 
disorders like hypercholesterolemia, alcohol, 
supplements and drug users, were excluded from 
the study. Ten patients including 6 and 3 subjects 
from cumin and vitamin E groups respectively, and 
also one subject from control group, withdrew 
during the study.The laboratory data as well as 
questionnaires data were collected for analysis. 
Study design 
The patients were randomly assigned into 3 
groups. The first group received cumin essential 
oil(in capsules resembling placebo and vitamin E 
capsules), the second group received vitamin E and 
the third group served as control and received oral 
gelatin capsules as placebo for a period of 3 
months. Dosage of vitamin E was based on a 
similar study (12) and after approval by the 
physician, 800 IU (150 mg) was selected. Cumin 
dosage was determined as 25 mg/day according to 
the manufacturer's instructions. At the beginning of 
the study and after 90 days of intake of supplements 
in each group, 10 ml venous blood in fasting  
state was collected from all participants. Blood 
serum were stored at -20°C before measuring 
leptin, lipid profile,paraoxonase1,levels. Whole 
blood containing EDTA was used HbA1c level 
measurement. 
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Biochemical analyzes 
Blood glucose and lipid profile were measured 
using the autoanalyzer (BT-3000- Italy) and 
appropriate commercial kits from Pars Azmoon, 
Iran. Apolipoprotein A1 (ApoA1) and apolipo-
protein B (ApoB) were measured by immuno-
turbidimetry.Serum levels of leptin and oxLDL 
were detected by ELISA kit (Mercodia, Sweden). 
HbA1c was measured using column chromato-
graphy with Nycocard Reader II. 
Arylesterase activity of paraoxonase 1 was 
measured using phenylacetate as the substrate, by 
spectrophotometric method (11). 
Statistical analyzes 
The statistical analysis were conducted by 
SPSS software (version 18) using repeated 
measures ANOVA and independent t-test. P value 
<0.05 was considered as statistically significant. 
 
Results 
The demographic characteristics and age 
distribution of the study population are shown in 
table 1. There was no significant difference 
between the 3 groups in body mass index, sex, age 
and blood pressure. 
Biochemical data are summarized in table 2. 
As shown in this table, the results indicate 
adecrease in oxLDL and a significant increase in 
paraoxonase 1 in Vitamin E group by the end of the 
third month (P<0.05). Results in cumin group 
showed a decrease in blood glucose, HbA1C, 
triglyceride, leptin and ox-LDL. Apo A1 and 
paraoxonase1 were increased after three months 
cumin intake (P<0.05). 
 
Discussion 
In this study, some biochemical parameters 
were measured after three months of vitamin E and 
cumin essential oil intake by diabetic patients. The 
data before and after intake were compared. 
Reduced level of oxLDL after vitamin E 
intake, is probably due to the antioxidant features of 
vitamin E and protective role of this vitamin in lipid 
oxidation,such that by reducing the quantity of 
oxidants, oxLDL is also reduced. 
Following vitamin E intake, paraoxonase 1 
enzyme activity has been increased in blood, 
showing that decrease in oxidative stress and 
oxidized lipids leads to higher enzyme activity. Our 
data suggest a specific relation between the 
increased enzyme activity and a decrease in lipid 
oxidation. 
 
Table 1. The demographic characteristics. 
 Group (N) Mean SD P-value 
Age 
(years) 
Vit E (32) 
Cumin (29) 
Control (34) 
57 
59 
61 
6.88 
6.9 
6.56 
 
0.069 
 
Weight 
(kg) 
Vit E (32) 
Cumin (29) 
Control (34) 
77.8 
80 
73.8 
11.9 
16.5 
9.30 
 
0.338 
 
BMI 
(kg/m2) 
Vit E (32) 
Cumin (29) 
Control (34) 
28.59 
29.4 
29.43 
4.18 
5.80 
4.02 
 
0.852 
 
Systolic bp (mmHg) Vit E (32) 
Cumin (29) 
Control (34) 
138 
140 
139 
12.2 
8.10 
18.2 
 
0.952 
 
Diastolic bp (mmHg) Vit E (32) 
Cumin (29) 
Control (34) 
76.5 
72 
76.88 
8.83 
7.53 
10.9 
 
0.657 
 
Data as mean± SD; N= patients per group 
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Table 2. A comparison of Biochemical variables before and after the study. 
Groups (N=105) 
 
Variables 
Cumin (29) Vit E (32) Control (34) 
Before- 
 
After- P value Before After P value Before After P  
value 
HbA1c (%) 8.55±0.4 7.35±0.21 0.003 7.99±0.4 8.53±0.4 0.164 8.68±0.3 9.08±0.3 0.12 
Glucose (mg/dl) 144.9±7.9 116.4±3.7 0.001 157.4±19 150.3±20 0.506 160±11.2 181±11.3 0.037 
Triglyceride (mg/dl) 204.3±32 158.6±22 0.050 364±441 254±231 0.065 264.2±37 288±38 0.237 
Cholesterol (mg/dl) 136.2±5 137.3±5 0.724 143.3±9.2 143.3±7.6 0.970 145.5±6.9 150.7±6.7 0.136 
Uric. Acid (mg/dl) 4.96±0.3 4.93±0.3 0.838 4.4±0.3 4.5±0.2 0.475 5±0.3 5±0.3 0.644 
Leptin (µg/ml) 26.38±8.3 20.2±5.8 0.008 24.9±7.6 24.8±6.2 0.971 24.7±5.1 33.6±6.5 0.023 
HDL (mg/dl) 35.3±2.2 38.7±2.3 0.087 38±3.7 37.8±2.2 0.938 34.3±2.1 32.4±2.7 0.215 
oxidized-LDL (U/L) 100.7±4.5 90.3±3.9 0.000 102.9±3.6 89.3±3.5 0.000 100.5±4.6 102.4±4.4 0.646 
Paraoxonase1 (U/L) 65.3±6.7 83.3±7.8 0.017 69.1±7.7 90.3±10.5 0.046 67.7±7.2 69.3±6.3 0.632 
ApoA1 (mg/dl) 102.9±4.6 115.4±4.5 0.014 103.6±5.3 110.5±4.7 0.098 102.3±5.7 97.7±5.2 0.241 
Apo B (mg/dl) 103.1±5.5 98.6±4.2 0.347 104.2±6.1 99.6±5.1 0.329 98.7±7.2 115.8±7.2 0.153 
LDL (mg/dl) 69.8±4.4 71.8±5.2 0.561 61.9±8.7 66.6±8.3 0.119 73.1±7.7 77.9±7.3 0.265 
Data presented as mean± SD; N= 30 per group. HbA1c (A1 glycated hemoglobin), HDL (high-density lipoprotein), LDL (low density lipoprotein), ApoA1 
(apolipoprotein A1), Apo B (apolipoprotein B). 
 
Shinde et al. have performed a study on 120 
type 2 diabetic patients after three months vitamin 
E intake, showing a decrease in oxidative stress and 
an increase in antioxidant enzymes  activity such as 
paraoxonase1 (13). But in contrast to the present 
study, Sarandolet al. showed that after three months 
vitamin E intake, no changes occurred in the 
activity of either the paraoxonase1or ApoB (14). 
A study by Reaven et al. showed that 1600 IU 
vitamin E intake per day in men aged 50 to 70 years 
and having type 2 diabetes mellitus, led to LDL 
oxidation decrease in comparison with the control 
group (15). 
Paraoxonase1 activity increase and oxLDL 
level decrease observed in the present study are 
consistent with most of the findings of the above 
mentioned studies. Obviously, these changes were 
anticipated based on the antioxidant characteristics 
of vitamin E.The effects of cumin on oxLDL level 
and paraoxonase1 activity were similar to  
vitamin E. 
There are contradictory ideas about the effect 
of vitamin E on glycemic control. Gazes et 
al.showed that HbA1c was significantly reduced in 
type 2 diabetic patients, after 1600 IU a day intake 
of alpha-tocopherolfor a period of 8 weeks (16), but 
our data did not confirm this finding. The 
discrepancy can be due to the difference in the 
vitamin dosage used which was more than double 
in comparison with the present study. The other 
factor which may affect the data is the difference in 
the patient’s diet which was not under our control. 
Also, the medication used for lowering patient’s 
blood sugar was different among the subjects which 
may have an impact on the outcome of data.  
In a study by Paolisso et al., where type 2 
diabetics received 900 mg/day alpha-tocopherol for 
a period of three months, the level of HbA1c was 
significantly reduced (17). However, in the study of 
Ble-castillo' et al., oral intake of α-tocopherol 800 
IU/day by overweight female subjects, no change in 
blood glucose was observed, but HbA1c was 
markedly reduced (18). Relatively, the results of the 
present study have shown that vitamin E has no 
clear effect on HbA1c level. 
Merzouk et al. showed that vitamin E intake 
reduced the total cholesterol, triglycerides, LDL 
and ApoB levels (19) whilst in a study by Cinaz et 
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al., no significant difference was found between 
serum levels of cholesterol and triglycerides (20). 
In the present study, the level of HDL and 
cholesterol showed no changes but triglycerides 
level was slightly reduced. It is possible that more 
noticeable changes would be anticipated by 
extended use or an increase in vitamin E dosage. 
Because the intake of vitamin E has no effect 
on the sugar, no significant changes in HbA1c has 
been expected. We speculate that vitamin E has no 
effect in the control of dyslipidemia as no 
significant changes have been observed in the level 
of cholesterol, triglycerides, HDL, the mass of fat 
cells and fat tissue leptin level, after this 
supplement intake.  
In a study by Ben et al., performed on 30 
patients with type 2 diabetes, it was shown that 
vitamin E can have a negative regulatory effect on 
leptin secretion (21). Chappell et al. have evaluated 
the effect of antioxidants such as vitamin E on 
pregnant women and indicated that leptin was 
reduced by vitamin E intake (22), which has not 
been observed in our study. In a study conducted on 
pigs by Kükner et al., there was no difference 
between the leptin expression in the control group 
and the group treated with vitamin E (23). 
Similarly, in the present study Vitamin E did not 
have any effect on leptin. We speculate that genetic 
factors or different intake dosage of vitamin E can 
be the determining factors in such difference. 
The present study showed that cumin essential 
oil intake for a period of three months caused a 
significant decrease in blood glucose, HbA1c, 
triglycerides, leptin, ox-LDL and a significant 
increase in paraoxonase 1 and ApoA1 concentra-
tion. 
Reduction of ox-LDL can be caused by 
antioxidant properties of cuminum cyminum (24) 
and the presence of flavonoids in its composition 
(25). Therefore, we anticipate that increasing the 
amount of paraoxonase 1 as an effective antioxidant 
enzyme may lead to the lipid oxidation reduction. 
Iron, zinc and manganese are among the compo-
nents of the cuminum cyminum (26). 
So it is possible that the presence of 
manganese in the structure of cumin helps the 
antioxidant enzymes such as manganese containing 
superoxide dismutase, to reduce the ox-LDL level. 
In addition to the anti-oxidant property, cumin 
may have a specific effect in increasing HDL and 
lowering blood cholesterol, by increasing Apo A1. 
Although the increase in ApoA1 has not been 
observed in some studies (10), but increased level 
of paraoxonase1 and decreased level of ox-LDL are 
consistent with the findings of the present study. 
Some studies have reported a decrease in 
blood sugar, triglycerides, cholesterol and increase 
of HDL following cumin intake (27, 28), although 
another research suggested that cumin has no  
effect on lowering the cholesterol level (29). We 
observed no changes in cholesterol levels, but 
confirmed a decrease in blood sugar and trigly-
cerides levels. 
Cumin intake was the cause of blood glucose 
decrease in some of the above studies.This effect 
may be due to high levels of manganese and zinc in 
cumin. It was demonstrated that manganese and 
zinc are involved in the production and secretion of 
insulin, insulin sensitivity and carbohydrate 
metabolism (30). The specific action of cumin  
may be due to the presence of cuminaldehyde 
which inhibits aldose reductase and alpha-
glucosidase, as two enzymes which can help 
diabetes progression (9). 
Three months after cumin essence intake, a 
reduction inleptin as white adipose mass index was 
observed which is consistent with the cumin anti-
dyslipidemic effects. Due to the fact that cumin has 
a direct effect on insulin and leptin and both of 
them have an inhibitory effect on appetite and 
neuropeptide Y, it is likely that cumin has imposed 
its effect on these two hormones through the 
intervention in hypothalamic signals. On the other 
hand with regards to the effect of cumin on 
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induction of insulin (31), this mechanism can be 
imposed indirectly on leptin through insulin. 
Although not many studies have been 
performed yet on the relationship between leptin 
and cumin intake, the results of this study are 
consistent with other studies findings. 
The difference in our data in comparison with 
other studies may be due to several factors such as 
type of vitamin E, type of cumin essence, subjects’ 
genetic background or duration of intake or 
inadequate dose used in our study. 
In addition, in numerous studies each patient 
has used different medications for treatment of 
diabetes which can have an impact on the results 
outcome. On the other hand, diet type which 
certainly has an impact on the present study and 
data outcome, was not under our control. 
The present study showed that improvement 
of lipid profile was more efficient with cumin 
intake in comparison with vitamin E.Cumin has 
been shown to reduce LDL oxidation by 
antioxidant activity and improve HDL composition 
by increasing Apo A levels.Therefore, cumin can 
be more effective than vitamin E in the prevention 
of cardiovascular complications in diabetic patients. 
Cumin was found to have a better hypoglycemic 
effect than vitamin E. According to the present 
study, cumin can help control diabetes mellitus 
complications while this feature is not seen with 
vitamin E.The results of the present study may 
provide additional information on the control of 
diabetes complications and could help in reducing 
the damage of glycated proteins in diabetic patients. 
Also, vitamin E may reduce some complications in 
diabetic patients. Obviously, cumin in comparison 
with vitamin Ecan reduce more effectively the 
complications of diabetes. 
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